Mild cognitive impairment and major depressive disorder are associated with molecular senescence abnormalities in older adults

32Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Introduction: The biological mechanisms linking mild cognitive impairment (MCI) and major depressive disorder are not well understood. We investigated whether molecular senescence changes in older adults are associated with a history of major depressive disorder (MDD) or MCI. Methods: We included 371 participants: 167 with MCI; 62 cognitively normal with a history of MDD; 97 with MDD+MCI; and 45 cognitively unimpaired (CU) without a history of MDD. The candidate Senescence-Associated Secretory Phenotype (SASP) biomarkers were measured in the plasma using a customized LUMINEX assay. Results: The MDD+MCI group had a higher SASP index than the other groups (P

Cite

CITATION STYLE

APA

Diniz, B. S., Vieira, E. M., Mendes-Silva, A. P., Bowie, C. R., Butters, M. A., Fischer, C. E., … Rajji, T. K. (2021). Mild cognitive impairment and major depressive disorder are associated with molecular senescence abnormalities in older adults. Alzheimer’s and Dementia: Translational Research and Clinical Interventions, 7(1). https://doi.org/10.1002/trc2.12129

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free